List of bibliographic references indexed by Influenza Vaccines (adverse effects)
Number of relevant bibliographic references: 88.
[20-40] [
0 - 20][
0 - 50][
40-60]
Ident. | Authors (with country if any) | Title |
---|
000F00 (2014) |
Keith S. Reisinger [États-Unis] ; Sandra J. Holmes [États-Unis] ; Paola Pedotti [États-Unis] ; Ashwani Kumar Arora [États-Unis] ; Maria Lattanzi [États-Unis] | A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination |
000F88 (2014) |
Loes De Vries [Pays-Bas] ; Florence Van Hunsel [Pays-Bas] ; Benedikte Cuppers-Maarschalkerweerd [Pays-Bas] ; Eugène Van Puijenbroek [Pays-Bas] ; Kees Van Grootheest [Pays-Bas] | Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: Description of a prospective cohort and spontaneously reported pregnancy‐related adverse reactions in the Netherlands |
001108 (2014) |
Claudia Vellozzi [États-Unis] ; Shahed Iqbal [États-Unis] ; Brock Stewart [États-Unis] ; Jerome Tokars [États-Unis] ; Frank Destefano [États-Unis] | Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic |
001241 (2013) |
F. Chavant [France] ; I. Ingrand ; A P Jonville-Bera ; C. Plazanet ; V. Gras-Champel ; L. Lagarce ; M. Zenut ; A. Disson-Dautriche ; S. Logerot ; M. Auffret ; A. Coubret-Dumas ; M L Bruel ; M. Boyer ; M A Bos-Thompson ; G. Veyrac ; P. Carlier ; M N Beyens ; S. Lates ; C. Damase-Michel ; A. Castot ; C. Kreft-Jaïs ; M C Pérault-Pochat | The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. |
001299 (2013) |
Gregory A. Poland [États-Unis] ; Douglas M. Fleming ; John J. Treanor ; Eugene Maraskovsky ; Thomas C. Luke ; Emma M A. Ball ; Caroline M. Poland | New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. |
001332 (2013) |
Laure F. Pittet [Suisse] ; Klara M. Posfay-Barbe | Immunization in transplantation: review of the recent literature. |
001385 (2013) |
Barbara A. Pahud [États-Unis] ; S Elizabeth Williams ; Cornelia L. Dekker ; Neal Halsey ; Philip Larussa ; Roger P. Baxter ; Nicola P. Klein ; Colin D. Marchant ; Robert C. Sparks ; Kathleen Jakob ; Laurie Aukes ; Susan Swope ; Elizabeth Barnett ; Paige Lewis ; Melvin Berger ; Stephen C. Dreskin ; Peter D. Donofrio ; James J. Sejvar ; Barbara A. Slade ; Jane Gidudu ; Claudia Vellozzi ; Kathryn M. Edwards | Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. |
001403 (2013) |
Silvia Candela [Italie] ; Sara Pergolizzi ; Pietro Ragni ; Silvio Cavuto ; Lucia Nobilio ; Simona Di Mario ; Valentina Dragosevic ; Nicola Groth ; Nicola Magrini | An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one. |
001412 (2013) |
Maria Luisa Moro [Italie] ; Lucia Nobilio ; Claudio Voci ; Simona Di Mario ; Silvia Candela ; Nicola Magrini | A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two. |
001521 (2013) |
Philip Cs De Whalley [Royaume-Uni] ; Andrew J. Pollard [Royaume-Uni] | Pandemic influenza A (H1N1) 2009 vaccination in children: A UK perspective |
001980 (2012) |
Constantino L Pez-Macías | Virus-like particle (VLP)-based vaccines for pandemic influenza |
001A24 (2012) |
Flor M. Munoz [États-Unis] | Safety of influenza vaccines in pregnant women. |
001A32 (2012) |
Joanne M. Langley [Canada] ; Dennis Reich ; Naresh Aggarwal ; David Connor ; Marc H. Lebel ; Anil Gupta ; Hartley Garfield ; Ping Li ; Anu Madan ; David W. Vaughn | Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. |
001A33 (2012) |
David L. Gordon ; Dimitar Sajkov ; Richard J. Woodman ; Yoshikazu Honda-Okubo ; Manon M. J. Cox [États-Unis] ; Susanne Heinzel ; Nikolai Petrovsky | Randomized Clinical Trial Of Immunogenicity And Safety Of A Recombinant H1N1/2009 Pandemic Influenza Vaccine Containing Advax™ Polysaccharide Adjuvant |
001A39 (2012) |
Kevin A. Ault [États-Unis] ; R Phillips Heine ; Laura E. Riley | Programmatic and research priorities for improving influenza immunization of pregnant women. |
001A47 (2012) |
Sarah J. Clark [États-Unis] ; Anne E. Cowan ; Pascale M. Wortley | Perspectives of allergists/immunologists on the 2009-2010 H1N1 vaccination effort. |
001B02 (2012) |
Heimo Lagler [Autriche] ; Katharina Grabmeier-Pfistershammer [Autriche] ; Veronique Touzeau-Römer [Autriche] ; Selma Tobudic [Autriche] ; Michael Ramharter [Autriche, Allemagne] ; Judith Wenisch [Autriche] ; Guido Andrés Gualdoni [Autriche] ; Monika Redlberger-Fritz [Autriche] ; Theresia Popow-Kraupp [Autriche] ; Armin Rieger [Autriche] ; Heinz Burgmann [Autriche] | Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals |
001B65 (2012) |
David W. Scheifele [Canada] ; Brian J. Ward ; Marc Dionne ; Otto G. Vanderkooi ; Mark Loeb ; Brenda L. Coleman ; Yan Li | Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trial. |
001B87 (2012) |
Iván Bihari [Hongrie] ; Gyula Pánczél [Hongrie] ; Jozsef Kovacs [États-Unis] ; Jenny Beygo [États-Unis] ; Elena Fragapane [États-Unis] | Assessment of Antigen-Specific and Cross-Reactive Antibody Responses to an MF59-Adjuvanted A/H5N1 Prepandemic Influenza Vaccine in Adult and Elderly Subjects |
001B99 (2012) |
Humberto Reynales [Colombie] ; Pedro Astudillo ; Serge De Vallière ; Christoph Hatz ; Patricia Schlagenhauf ; Barbara Rath ; Priscilla Velentgas ; Ariel Fari A ; Victor Sales-Carmona ; Nicola Groth | A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic. |
002079 (2012) |
Lisa A. Jackson [États-Unis] ; Wilbur H. Chen [États-Unis] ; Jack T. Stapleton [États-Unis] ; Cornelia L. Dekker [États-Unis] ; Anna Wald [États-Unis] ; Rebecca C. Brady [États-Unis] ; Srilatha Edupuganti [États-Unis] ; Patricia Winokur [États-Unis] ; Mark J. Mulligan [États-Unis] ; Harry L. Keyserling [États-Unis] ; Karen L. Kotloff [États-Unis] ; Nadine Rouphael [États-Unis] ; Diana L. Noah [États-Unis] ; Heather Hill [États-Unis] ; Mark C. Wolff [États-Unis] | Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Influenza Vaccines (adverse effects)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Influenza Vaccines (adverse effects)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Influenza Vaccines (adverse effects)
}}
| This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021 | ![](Common/icons/LogoDilib.gif) |